[1]
“Comparison Of Sofosbuvir Plus Daclatsvir With Sofosbuvir Alone In Achieving Svr In Dialysis Dependent Chronic Hepatitis C Patients”, Journal of Pharmaceutical Negative Results, pp. 3172–3179, Mar. 2023, doi: 10.47750/pnr.2023.14.03.397.